Page last updated: 2024-12-05

3,5-dinitrosalicylic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-Dinitrosalicylic acid (DNSA) is a yellow crystalline solid that is commonly used as a reagent in analytical chemistry, particularly for the determination of reducing sugars. It is synthesized by the nitration of salicylic acid with a mixture of nitric acid and sulfuric acid. DNSA reacts with reducing sugars in alkaline conditions to form a colored product, which can be quantified spectrophotometrically. The reaction is highly sensitive and specific for reducing sugars, making DNSA a valuable tool for analyzing food, biological samples, and industrial products. The reaction mechanism involves the oxidation of the reducing sugar by DNSA, leading to the formation of a colored product, which is believed to be a 3-amino-5-nitro-salicylic acid derivative. DNSA is also used in the synthesis of other organic compounds, such as dyes and pharmaceuticals. The compound is studied extensively due to its unique chemical properties and its applications in various fields. '
```

3,5-dinitrosalicylic acid: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3,5-dinitrosalicylic acid : A monohydroxybenzoic acid consisting of 2-hydroxybenzoic acid having nitro substituents at the 3- and 5-positions. It is used in colorimetric testing for the presence of free carbonyl groups (C=O) in reducing sugars. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID11873
CHEMBL ID2260697
CHEBI ID53648
SCHEMBL ID125292
MeSH IDM0088129

Synonyms (58)

Synonym
nsc 181
brn 2220661
ai3-15341
3,5-dinitrosalicylic acid (lead salt) (dry) [forbidden]
einecs 210-204-3
2act5nw8hu ,
unii-2act5nw8hu
3,5-dinitrosalicylic acid (lead salt) (dry)
OPREA1_730607
c7h4n2o7
salicylic acid, 3,5-dinitro-
benzoic acid,3,5-dinitro,2-hydroxy
inchi=1/c7h4n2o7/c10-6-4(7(11)12)1-3(8(13)14)2-5(6)9(15)16/h1-2,10h,(h,11,12
benzoic acid, 2-hydroxy-3,5-dinitro-
STK369406
nsc181
609-99-4
3,5-dinitrosalicylate
salicylic acid,5-dinitro-
3,5-dinitro-2-hydroxybenzoic acid
2-hydroxy-3,5-dinitrobenzoic acid
nsc-181
3,5-dinitrosalicylic acid
3,5-dinitrosalicylic acid, used in colorimetric determination of reducing sugars
NCGC00166042-01
3,5-dinitrosalicylic acid, 98%
D1134
AC-7850
AKOS001586271
CHEBI:53648 ,
o-dncp
dnsa
o-dinitrocarboxylphenol
3,5-dinitro-2-salicylic acid
A23182
BBL000693
D0850
FT-0614725
AG-205/03640014
EPITOPE ID:117712
S12284
CHEMBL2260697
3,5-dinitro-salicylic acid
SCHEMBL125292
2-hydroxy-3,5-dinitro-benzoic acid
DTXSID9060576
W-105211
mfcd00007104
3,5-dinitrosalicylic acid, p.a., 99%
2-hydroxy-3,5-dinitrobenzoicacid
Q223030
AS-15533
3,5-dinitrosalicylsa currencyure
3,5-dinitrosalicylic acid 100 ng/ml in water
CS-W010410
tci-d 0850
SY014324
AKOS040744592
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
haptenAny substance capable of eliciting an immune response only when attached to a large carrier such as a protein. Examples include dinitrophenols; oligosaccharides; peptides; and heavy metals.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
monohydroxybenzoic acidAny hydroxybenzoic acid having a single phenolic hydroxy substituent on the benzene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (5)

Assay IDTitleYearJournalArticle
AID1145616Increase in membrane potential in mollusc neurons assessed as conductance of potassium at pH 7.8 relative to salicylic acid1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145607Octanol-aqueous phase distribution coefficient, log D of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145615Dissociation constant, pKa of the compound at pH 7.81977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145614Dissociation constant, pKa of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
AID1145605Octanol-water partition coefficient, log P of the compound1977Journal of medicinal chemistry, Jan, Volume: 20, Issue:1
Use of distribution coefficients in quantitative structure-activity relationships.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (15.38)18.7374
1990's1 (3.85)18.2507
2000's5 (19.23)29.6817
2010's12 (46.15)24.3611
2020's4 (15.38)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.76 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index5.26 (4.65)
Search Engine Demand Index67.69 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.85%)4.05%
Observational0 (0.00%)0.25%
Other25 (96.15%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]